The company's hydrogel-based systems enable accurate, low-cost, and multi-parameter testing at the point-of-care. Aquila Diagnostics focuses on commercializing nucleic acid-based rapid diagnostic tests for infectious pathogens and genetic markers. Their portable device and disposables allow for timely detection of multiple targets in small volumes of biofluids.